Innocan, Pharma

Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach

Published on 08/07/2025 at 18:03 | prnewswire.co.uk

Innocan Pharma Corporation Canada Israel Ontario

en | boerse | 67998490 |